CompletedNCT03720899
NicoBloc Compared With Nicotine Lozenges for Quitting Smoking
About this title
Read the official source — NCT03720899Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- BirminghamSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: March 21, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 45
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03720899
- Official title
Show the full official title
A Pilot Trial Comparing NicoBloc to Nicotine Lozenges: Initial Acceptability and Feasibility Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Did this study involve medication?
Yes. The study involved medication, including NicoBloc and Nicotine Lozenge.
Who was this study for?
Listed age limits: from 18 years.
